In a genetically modified mouse model in which the WTAPELL motif was deleted from the ANF-RGC gene, hypertension and cardiac hypertrophy were observed (Duda et al., 2013; United States Patent No. 8835711 issued on September 16, 2014; Patent Publication Number: 20130291132). The gene discussed is NPPA; the disease is hypertensive disorder.